https://www.selleckchem.com/products/foxy5.html
Type 2 diabetes mellitus (T2DM) greatly increases cardiovascular risk. Primary and secondary cardiovascular prevention lead to lower cardiovascular events, improved quality of life and lower costs related to complications. To estimate the proportion of patients with T2DM undergoing drug therapy for cardiovascular prevention (aspirin and statins) in Colombia and to describe the change in patterns of use between 2008 and 2018. This was a cross-sectional study comparing prescriptions for aspirin and statins in 2008 and in 2018 in outpatients
Like
Comment
Share
